Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 57, Issue 2, 1998, Pages 70-78

  Herrick, Ariane L ^a   Clark, Stuart ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPILLAROSCOPY; DOPPLER ECHOGRAPHY; FINGER BLOOD FLOW; HUMAN; LASER DOPPLER FLOWMETRY; PERIPHERAL VASCULAR DISEASE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAYNAUD PHENOMENON; REVIEW; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; THERMOGRAPHY;

EID: 0031956374     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.2.70     Document Type: Review

References (88)

1. Allen EV, Brown GE. Raynaud's disease: a critical review of minimal requisites for diagnosis. Am J Med Sci 1932;183:187-200.
2. Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975;4:351-68.
3. Prescott RJ, Freemont AJ, Jones CJP, Hoyland J, Fielding P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992;166:255-63.
4. Jayson MIV. Systemic sclerosis: a collagen or microvascular disease? BMJ 1984;288:1855-7.
5. LeRoy EC. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis 1992;51:286-8.
6. Engelhart M, Seibold JR. The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon. Angiology 1990;41:715-23.
7. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by 'wide-field' microscopy. Arthritis Rheum 1973;16:619-28.
8. Bollinger A, Fagrell B. Clinical capillaroscopy. Toronto: Hogrefe and Huber, 1990.
9. Bukhari M, Herrick AL, Moore T, Manning J, Jayson MIV. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol 1996;35:1127-31.
10. Kabasakal Y, Elvins DM, Ring EFJ, NcHugh NJ. Quantitative nailfold microscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996;55:507-12.
11. Lee P, Leung FY, Alderdice C, Armstrong SK. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 1983;10:930-8.
12. Lefford F, Edwards JCW. Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 1986;45:741-9.
13. Maricq HR. Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res 1986;32:271-6.
14. Houtman PM, Kallenberg CGM, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. J Rheumatol 1986;13:556-63.
15. Statham BN, Rowell NR. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome. Acta Derm Venereol (Stockh) 1986;66:139-43.
16. Carpentier PH, Maricq HR. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 1990;16:75-91.
17. ter Borg EJ, Piersma-Wichers G, Smit AJ, Kallenberg CGM, Wouda AA. Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma. Semin Arthritis Rheum 1994;24:40-7.
18. Michoud E, Poensin D, Carpentier PH. Digitized nailfold capillaroscopy. Vasa 1994;23:35-42.
19. Bollinger A, Jager K, Siegenthaler W. Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med 1986;146:1541-5.
20. Grassi W, Core P, Carlino G, Cervini C. Acute effects of single dose nifedipine on cold-induced changes of microvascular dynamics in systemic sclerosis. Br J Rheumatol 1994;33:1154-61.
21. Mahler F, Saner H, Boss C, Annaheim M. Local cold exposure test for capillaroscopic examination of patients with Raynaud's syndrome. Microvasc Res 1987;33:422-7.
22. Jacobs MJMM, Lemmens HAJ. Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil. Int J Microcirc Clin Exp 1985;4:63-8.
23. Hahn M, Klyscz T, Junger M, Rassner G. Local cold exposure test as therapy control in patients with Raynaud's phenomenon: comparison between laser Doppler fluxmetry and simultaneous red blood cell velocity measurements in nailfold capillaries. Br J Dermatol 1995;133:704-9.
24. Schabauer AMA, Rooke TW. Cutaneous laser Doppler flowmetry: applications and findings. Mayo Clin Proc 1994;69:564-74.
25. Gush RJ, King TA. Discrimination of capillary and arteriovenular blood flow in skin by laser Doppler flowmetry. Med Biol Eng Comput 1991;29:387-92.
26. Goodfield MJD, Hume A, Rowell NR. The effect of simple rewarming procedures on finger blood flow in systemic sclerosis. Br J Dermatol 1988;118:661-8.
27. Graafsma SJ, Wollersheim H, Droste HT, ten Dam MAGJ, van Tits LJH, Reyenga J, et al. Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon. Clin Sci 1991;80:325-31.
28. Valentini G, Leonardo G, Moles DA, Apaia MR, Maselli R, Tirri G, et al. Transcutaneous oxygen pressure in systemic sclerosis: evaluation at different sensor temperatures and relationship to skin perfusion. Arch Dermatol Res 1991;283:285-8.
29. Walmsley D, Goodfield MJD. Evidence for an abnormal peripherally mediated vascular response to temperature in Raynaud's phenomenon. Br J Rheumatol 1990;29:181-4.
30. Engelhart M, Kristensen JK. Raynaud's phenomenon: blood supply to fingers during indirect cooling, evaluated by laser Doppler flowmetry. Clin Physiol 1986;6:481-8.
31. Lau CS, Khan F, Brown R, McCallum P, Belch JJF. Digital blood flow responses to body warming, cooling, and rewarming in patients with Raynaud's phenomenon. Angiology 1995;46:1-10.
32. Goodfield M, Hume A, Rowell N. Reactive hyperemic responses in systemic sclerosis patients and healthy controls. J Invest Dermatol 1989;93:368-71.
33. Wollersheim H, Reyenga J, Thein T. Postocclusive reactive hyperemia of fingertips, monitored by laser Doppler velocimetry in the diagnosis of Raynaud's phenomenon. Microvasc Res 1989;89:286-95.
34. Wigley FM, Wise RA, Mikdashi J, Schaefer S, Spence RJ. The post-occlusive hyperemic response in patients with systemic sclerosis. Arthritis Rheum 1990;33:1620-5.
35. Toms SL, Cooke ED. A comparison of the functioning of arterivenous anastomoses in secondary Raynaud's phenomenon and control subjects in response to local hand warming. Int Angiol 1995;14:74-9.
36. Geirsson AJ, Jonsson GS, Asgeirsdottir LP. Functional study of the dermal microcirculation in systemic sclerosis. Scand J Rheumatol 1994;23:73-6.
37. Aghassi D, Monoson T, Braverman I. Reproducible measurements to quantify cutaneous involvement in scleroderma. Arch Dermatol 1995;131:1160-6.
38. Bartelink ML, Wollersheim H, Leesmans E, de Boo T, Thein T. A standardised finger cooling test for Raynaud's phenomenon: diagnostic value and sex differences. Eur Heart J 1993;14:614-22.
39. Bartelink ML, Wollersheim H, Jansen RWM, Theeuwes A, Thein T. Reproducibility of the finger cooling test. Microvasc Res 1993;45:65-73.
40. Bunker CB, Reavley C, O'Shaughnessy DJ, Dowd PM. Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon. Lancet 1993;342:80-2.
41. Whitmore SE, Wigley FM, Wise RA. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon. J Rheumatol 1995;22:50-4.
42. Anderson ME, Hollis S, Moore T, Jayson MIV, Herrick AL. Non-invasive assessment of vascular reactivity in forearm skin of patients with primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol 1996;35:1281-8.
43. Khan F, Litchfield SJ, McLaren M, Veale DJ, Littleford RC, Belch JJF. Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthritis Rheum 1997;40:352-7.
44. Seifalian AM, Stansby G, Jackson A, Howell K, Hamilton G. Comparison of laser Doppler perfusion imaging, laser Doppler flowmetry, and thermographic imaging for assessment of blood flow in human skin. Eur J Vasc Surg 1994;8:65-9.
45. Chen Z, Milner TE, Dave D, Nelson JS. Optical Doppler tomographic imaging of fluid flow velocity in highly scattering media. Optics Letters 1997;22:64-6.
46. Feldman F. Thermography of the hand and wrist: practical applications. Hand Clin 1991;7:99-112.
47. Kyle V, Parr G, Salisbury R, Thomas PP, Hazleman B. Prostaglandin E1 vasospastic disease and thermography. Ann Rheum Dis 1985;44:73-8.
48. Darton K, Black CM. Pyroelectric vidicon thermography and cold challenge quantify the severity of Raynaud's phenomenon. Br J Rheumatol 1991;30:190-5.
49. O'Reilly D, Taylor L, El-Hadidy K, Jayson MIV. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis. Ann Rheum Dis 1992;51:1193-6.
50. Herrick A, El-Hadidy K, Marsh D, Jayson M. Abnormal thermoregulatory responses in patients with reflex sympathetic dystrophy syndrome. J Rheumatol 1994;21:1319-24.
51. Wesseling H, den Heeten A, Wouda AA. Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon. Eur J Clin Pharmacol 1981;20:329-33.
52. Martin MFR, Dowd PM, Ring EFJ, Cooke ED, Dieppe PA, Kirby JDT. Prostaglandin El infusions for vascular insufficiency in progressive systemic sclerosis. Ann Rheum Dis 1981;40:350-4.
53. McHugh NJ, Csuka M, Watson H, Belcher G, Amadi A, Ring EFJ, et al. Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. Ann Rheum Dis 1988;47:43-7.
54. Shawket S, Dickerson C, Hazleman B, Brown MJ. Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin. Br J Clin Pharmacol 1991;32:209-13.
55. Kyle MV, Belcher G, Hazleman BL. Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon. J Rheumatol 1992;19:1403-6.
56. Teh LS, Manning J, Moore T, Tully MP, O'Reilly D, Jayson MIV. Sustained-release glyceryl trinitrate patches as a treatment for primary and secondary Raynaud's phenomenon. Br J Rheumatol 1995;34:636-41.
57. Ring EFJ, Bacon PA. Quantitative thermographic assessment of inositol nicotinate therapy in Raynaud's phenomenon. J Int Med Res 1977;5:217-22.
58. Gush RJ, Taylor LJ, Jayson MIV. Acute effects of sublingual nifedipine in patients with Raynaud's phenomenon. J Cardiovasc Pharmacol 1987;9:628-31.
59. Neilson SL. Raynaud phenomena and finger systolic pressure during cooling. Scand J Clin Lab Invest 1978;38:765-70.
60. Maricq HR, Weinrich MC, Valter I, Palesch YY, Maricq JG. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders. J Rheumatol 1996;23:2068-78.
61. Wigley FM, Malamet R, Wise RA. Reproducibility of cold provocation in patients with Raynaud's phenomenon. J Rheumatol 1987;14:751-5.
62. Corbin DOC, Wood DA, Housley E. An evaluation of finger systolic-pressure response to local cooling in the diagnosis of primary Raynaud's phenomenon. Clin Physiol 1985;5:383-92.
63. Allen JA, Devlin MA, McGrann S, Dohery CC. An objective test for the diagnosis and grading of vasospasm in patients with Raynaud's syndrome. Clin Sci 1992;82:529-34.
64. Carter SA, Dean E, Kroeger EA. Apparent finger systolic pressures during cooling in patients with Raynaud's syndrome. Circulation 1988;77:988-96.
65. Leppert J. Limitation of finger systolic pressure measurement as a diagnostic test for primary Raynaud's phenomneon in a female population. Clin Physiol 1989;9:457-65.
66. Kurozawa Y, Nasu Y. Toe systolic pressure after local cooling in primary Raynaud's phenomenon. Int Angiol 1994;13:215-17.
67. Hoare M, Miles C, Girvan R, Ramsden J, Needham T, Pardy B, et al. The effect of local cooling on digital systolic pressure in patients with Raynaud's syndrome. Br J Surg 1982;69:S27-8.
68. Maricq HR, Diat F, Weinrich MC, Maricq JG. Digital pressure responses to cooling in patients with suspected early vs definite scleroderma (systemic sclerosis) vs primary Raynaud's phenomenon. J Rheumatol 1994;21:1472-6.
69. Leppert J, Jonasson T, Nilsson H, Ringqvist I. The effect of isradipine, a new calcium-channel antagonist, in patients with primary Raynaud's phenomenon: a single-blind dose-response study. Cardiovasc Drugs Ther 1989;3:397-401.
70. Weber A, Bounameaux H. Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease. J Cardiovasc Pharmacol 1990;15:853-5.
71. O'Reilly MJG, Talpos G, Roberts VC, White JM, Cotton LT. Controlled trial of plasma exchange in treatment of Raynaud's syndrome. BMJ 1979;1:1113-15.
72. Aylward M, Bater PA, Davies DE, Dewland PM, Lewis PA, Maddock J. Long-term monitoring of the effects of thymoxamine hydrochloride tablets in the management of patients with Raynaud's disease. Curr Med Res Opin 1982;8:158-70.
73. Klimiuk PS, Kay EA, Mitchell WS, Taylor L, Gush R, Gould S, et al. Ketanserin: an effective treatment regimen for digital ischaemia in systemic sclerosis. Scand J Rheumatol 1989;18:107-11.
74. Singh S, de Trafford JC, Baskerville PA, Roberts VC. Digital artery calibre measurement - a new technique of assessing Raynaud's phenomenon. Eur J Vasc Surg 1991;5:199-203.
75. Naidu S, Baskerville PA, Goss DE, Roberts VC. Raynaud's phenomenon and cold stress testing: a new approach. Eur J Vasc Surg 1994;8:567-73.
76. Singh S, de Trafford JC, Baskerville PA, Martin JF. Response of digital arteries to endothelial dependant and independant vavsodilators in patients with Raynaud's phenomenon. Eur J Clin Invest 1995;25:182-5.
77. McIlroy MB, Targett RC, Roussin A, Seitz WS. Doppler ultrasonic investigation of Raynaud's phenomenon: effect of temperature on blood velocity. Ultrasound Med Biol 1985;11:719-25.
78. Greenstein D, Gupta NK, Martin P, Walker DR, Kester RC. Impaired thermoregulation in Raynaud's phenomenon. Angiology 1995;46:603-11.
79. Greenstein D, Jeffcote N, Ilsley D, Kester RC. The menstrual cycle and Raynaud's phenomenon. Angiology 1996;47:427-36.
80. Brouwer RML, Wenting GJ, Schalekamp MADH. Acute effects and mechanism of action of ketanserin in patients with primary Raynaud's phenomenon. J Cardiovasc Pharmacol 1990;15:868-76.
81. Engelhart M, Neilsen HV, Kristensen JK. The blood supply to fingers during Raynaud's attack: a comparison of laser-Doppler flowmetry with other techniques. Clin Physiol 1985;5:447-53.
82. Pistorius MA, Planchon D, de Faucal P. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients. Int Angiol 1994;13:10-14.
83. Zamora MR, O'Brien RF, Rutherford RB, Weil JV. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet 1990;336:1144-7.
84. Cooke ED, Bowcock SA, Smith AT. Photoplethysmography of the distal pulp in the assessment of the vasospastic hand. Angiology 1985;36:33-40.
85. Suichies HE, Aarnoudse JG, Wouda AA, Jentink HW, de Mul FFM, Greve J. Digital blood flow in cooled and contralateral finger in patients with Raynaud's phenomenon. Comparative measurements between photoelectrical plethysmography and laser Doppler flowmetry. Angiology 1992;43:134-41.
86. Kallenberg GGM, Wouda AA, Meems L, Wesseling H. Once daily felodipine in patients with primary Raynaud's phenomenon. Eur J Clin Pharmacol 1991;40:313-15.
87. Lafferty K, de Trafford JC, Potter C, Roberts VC, Cotton LT. Reflex vascular responses in the finger to contralateral thermal stimuli during the normal menstrual cycle: a hormonal basis to Raynaud's phenomenon. Clin Sci 1985;68:639-45.
88. Cooke JP, Creager MA, Osmundson PJ, Shepherd JT. Sex differences in control of cutaneous blood flow. Circulation 1990;82:1607-15.